India ceftriaxone market is forecasted to grow at a steady pace during the forecast period. Ceftriaxone is an antibiotic which is utilized for curing a number of bacterial infections. The India ceftriaxone market is driven by surging population with urinary tract (UTI) and skin infections in India. Additionally, government initiatives for spreading awareness coupled with high investments for research activities by major market players are some other factors which is projected to bolster the market growth. Also, the medication is a popular drug choice for the treatment of bacterial meningitis which is further expected to boost the demand through FY2026.
The India ceftriaxone market is segmented based on
The major players operating in the India ceftriaxone market are Radicura Pharmaceuticals Pvt. Ltd, Wockhardt Limited (Taurus), Nectar Lifesciences Ltd., Qilu Pharmaceutical India Pvt. Ltd., Mankind Pharma Ltd., Fresenius Kabi India Pvt. Ltd., Virchow Healthcare Private Limited, Orchid Pharma Ltd., Ikon Remedies Pvt. Ltd., IPCA Laboratories Ltd, and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, portfolio expansions and new product developments.
Years considered for this report
Historical YearsFY2016-FY2019
Base YearFY2020
Estimated YearFY2021
Forecast PeriodFY2022–FY2026
Objective of the Study
- To analyze and estimate the market size of India ceftriaxone market from FY2016 to FY2019.
- To estimate and forecast the market size of India ceftriaxone market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India ceftriaxone market based on dose, source, form, distribution channel, application, end user, company, and regional distribution.
- To identify dominant region or segment in the India ceftriaxone market.
- To identify drivers and challenges for India ceftriaxone market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India ceftriaxone market.
- To identify and analyze the profile of leading players operating in India ceftriaxone market.
- To identify key sustainable strategies adopted by market players in India ceftriaxone market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of
Key Target Audience
- Ceftriaxone manufacturers/ suppliers/ distributors
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to ceftriaxone
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
